Catalyst Wire Dossier Catalyst Wire Dossier

Cystadrops

mercaptamine hydrochloride · Recordati Rare Diseases
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Cystadrops, covering 2020-08-19 to 2025-08-08. Get the full timeline:

Most recent: EMA Authorised: Cystadrops (mercaptamine hydrochloride) — Recordati Rare Diseases

See pricing